chlorthalidone · Prm Pharma · NDA 218647
Hemiclor
Earliest generic entry, as listed
4 Sep 2045
Blocked by patent: US 12667554.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 12667554 | product | 4 Sep 2045 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 25 Oct 2026Generic approved · 218647-0011 Jul 2026
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 218647 · 001 · RLD | tablet, oral | 12.5MG | 4 Sep 2045 |